O*nosma paniculata* Bureau & Franchet is a biennial herb belonging to the family Boraginaceae. The genus *Onosma* is represented by 145 species centered in Asia, out of which 29 species are found in mainland China.^[@ref1]^ The dried roots of this ("Dian Zi Cao") and related species (e.g., *Arnebia euchroma* \["Ruan Zi Cao"\], *Lithospermum erythrorhizon* \["Ying Zi Cao"\]) are used in traditional Chinese medicine for the treatment of various diseases including cancer.^[@ref2],[@ref3]^ Shikonin and alkannin derivatives are the main constituents and are found in at least 150 species of Boraginaceous genera including *Lithospermum*, *Echium*, and *Onosma*.^[@ref4]^ Their pharmacological activities range from wound-healing to anti-inflammatory, anticancer, and antimicrobial and antiviral properties.^[@ref5]−[@ref16]^ However, *O. paniculata* is presently little investigated regarding its constituents and pharmacological activities. In a previous study by our group, it was shown that a petroleum ether extract of the roots exhibited strong growth inhibitory activity toward cancer cell lines and induced cell death caspase-dependently.^[@ref17]^ We now have undertaken bioassay-guided fractionation and report the isolation and structure elucidation of the active principles and their effects on cancer cell lines.

Results and Discussion {#sec2}
======================

HPLC analysis of the active petroleum ether-soluble extract pointed to several shikonin derivatives.^[@ref17]^ Using preparative HPLC, seven fractions were collected, from which fractions 2, 4, 6, and 7 gave β-hydroxyisovalerylshikonin (**1**), acetylshikonin (**2**), dimethylacrylshikonin (**3**), and a mixture of α-methylbutyrylshikonin (**4**) and isovalerylshikonin (**5**), respectively.

![](np-2011-006499_0005){#fx1}

Since it has been demonstrated that biological activity can be lost due to polymerization during isolation processes,^[@ref4]^ the one-step isolation procedure used was a great benefit in the present work. The isolates were identified using ^1^H and ^13^C NMR and CD spectroscopic measurements (Tables S1 and S2, [Supporting Information](#notes-1)) and by comparison with published data.^[@ref12],[@ref18]^ Compounds **4**+**5** were obtained as a mixture and could not be separated, but ^1^H and ^13^C NMR data clearly revealed them to occur in a ratio of 2:1. The enantiomers shikonin and alkannin give identical NMR spectra^[@ref19]^ but vary in configuration at C-11. They are not capable of being differentiated by optical rotation with a sodium lamp as light source, but CD measurements may be used for this purpose. All isolated compounds exhibited a positive Cotton effect and were identified as shikonin derivatives.^[@ref19],[@ref20]^ This is the first report concerning the CD data of **1**--**3**.

###### IC~50~ (μM) Concentrations of Isolated Compounds after 72 h of Treatment[a](#t1fn1){ref-type="table-fn"}

                                                tumorigenic cell line           nontumorigenic cell line                                                                                                                                                                                                        
  --------------------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- -------------------------------
  **1**                                         0.6 ± 0.1                       4.6 ± 0.3                       23.6 ± 0.2                      4.1 ± 0.6                       8.3 ± 0.3                       13.0 ± 2.1                      12.7 ± 0.4                      30.9 ± 1.4                      3.9 ± 0.1
  **2**                                         1.0 ± 0.1                       11.3 ± 1.7                      15.9 ± 0.7                      9.0 ± 0.5                       13.0 ± 0.7                      30.7 ± 1.1                      23.5 ± 0.7                      71.5 ± 1.9                      2.6 ± 0.2
  **3**                                         1.9 ± 0.3                       23.2 ± 0.4                      30.8 ± 1.1                      20.0 ± 0.8                      1.1 ± 0.1                       2.3 ± 0.1                       2.7 ± 0.3                       8.3 ± 0.3                       2.4 ± 0.4
  **4**+**5**[b](#t1fn2){ref-type="table-fn"}   1.7 ± 0.1                       14.7 ± 1.7                      22.7 ± 1.4                      1.3 ± 0.1                       15.5 ± 0.4                      23.0 ± 1.8                      18.8 ± 0.5                      52.3 ± 0.8                      3.6 ± 0.2
  vinblastine                                   9.4 × 10^--3^ ± 2.0 × 10^--4^   3.1 × 10^--2^ ± 4.6 × 10^--3^   8.1 × 10^--3^ ± 1.0 × 10^--3^   8.7 × 10^--3^ ± 5.0 × 10^--4^   1.1 × 10^--2^ ± 1.6 × 10^--3^   3.5 × 10^--3^ ± 6.0 × 10^--4^   1.5 × 10^--2^ ± 2.4 × 10^--3^   4.2 × 10^--3^ ± 1.3 × 10^--3^   2.4 × 10^--2^ ± 3.3 × 10^--3^

Results are expressed as means ± SEM of six independent experiments. IC~50~ values were determined using the four-parameter logistic curve and individual values of all independent experiments.

Tested as an inseparable 2:1 mixture of **4**+**5**.

Subsequently, the compounds were evaluated for their cytotoxic potential using eight human cancer cell lines and human nontumorigenic MRC-5 lung fibroblasts. Cytotoxicity was compared to vinblastine, which was used as positive control (Table [1](#tbl1){ref-type="table"}). All isolated compounds exhibited cytotoxicity with IC~50~ values ranging from 600 nM to 70 μM. The most sensitive was the CCRF-CEM leukemia cell line, showing up to 6-fold lower IC~50~ values than MRC-5 cells. The four melanoma cell lines (SBcl2, WM35, WM9, and WM164) were isolated primarily from different stages of melanoma progression.^[@ref21]^ It has been shown that numerous genetic mutations leading to altered cell signaling are involved in the transformation from benign nevi to melanoma.^[@ref22]^ These changes enable melanoma cells to escape apoptosis and contribute to unrestricted cell proliferation. The effects of **3** and the mixture of **4**+**5** regarding cell morphology, cell-cycle distribution, and apoptosis induction were analyzed. Test compounds were freshly dissolved in DMSO and used immediately since storage in DMSO led to a considerable loss of activity. Compound **3** exhibited the lowest IC~50~ values toward melanoma cell lines, which is probably due to the presence of an unsaturated carbonyl group in the side chain. Morphological changes (Figure S3, [Supporting Information](#notes-1)) were observed after 24 h and continued up to 48 h. Cells exposed to the IC~50~ concentrations of **3** or **4**+**5** exhibited less density and a more round shape phenotype with fewer dendrites. It has been reported that shikonin induces apoptosis in several cell lines^[@ref23]−[@ref25]^ and affects the cell cycle.^[@ref24],[@ref26]^ However, compound **3** and **4**+**5** are less well investigated. Investigations of the cell-cycle distribution revealed that **3** and **4**+**5** strongly affected the amount of cells in the G1 phase and, accordingly, the G2/M or S phase. For **3**, it was found that there were up to 50% fewer cells in the G1 phase and an increasing number of cells in the S phase (SBcl2 and WM35) or G2/M phase (WM9 and WM164) (Figure [1](#fig1){ref-type="fig"}). In contrast to **3** and also **4**+**5**, shikonin led to an arrest in the G1 phase in melanoma^[@ref26]^ and bladder^[@ref24]^ cancer cells, while cells in the G2/M phase decreased, indicating a different mode of action. Additionally, cells in the subG1 region (up to about 20%) increased after 24 h (up to ca. 20%), indicating apoptotic cell death, which was confirmed using a CaspaseGlo 3/7 assay (Figure [2](#fig2){ref-type="fig"}). The results for cells exposed to the IC~50~\'s of **4**+**5** were similar (Figures S3--S5, [Supporting Information](#notes-1)).

![Treatment of melanoma cells with **3** reduced cells in the G1 phase and increased cells especially in the S-phase (SBcl2 (A) and WM35 (B)), and G2/M phase (WM9 (C) and WM164 (D)). Gray bars: Vehicle-treated control cells. Colored bars: Cells exposed to **3** (IC~50~). The times shown represent the duration of treatment, *n* = 3, with mean values shown. Areas from the bottom to the top: subG1 cells (black and purple), G1 phase cells (lower light gray and blue), S phase cells (dark gray and turquoise), and G2/M phase cells (upper light gray and green).](np-2011-006499_0002){#fig1}

![Caspase 3/7 activity measured using the Caspase-Glo 3/7 assay. Caspase activity peaked after 24 h when cells were exposed to the IC~50~ value of **3**, indicating apoptotic cell death.](np-2011-006499_0003){#fig2}

In summary, it has been shown that roots of *O. paniculata* are a rich source of acetylshikonin (**2**), dimethylacrylshikonin (**3**), α-methylbutyrylshikonin (**4**), and isovalerylshikonin (**5**). All of these compounds exhibited cytotoxicity toward a panel of cancer cell lines. For the melanoma cell lines used, the results indicated that **3** and the mixture of **4**+**5** affect the cell cycle and induce apoptosis.

Experimental Section {#sec3}
====================

General Experimental Procedures {#sec3.1}
-------------------------------

CD measurements were recorded on a JASCO J-715 spectropolarimeter, at 210--600 nm in CHCl~3~. NMR spectra were recorded in chloroform-*d*~1~ (Eurisotop, Saint-Aubin Cedex, France) on a Varian Unitylnova 400 MHz (400 MHz for ^1^H and 100 MHz for ^13^C) or 600 MHz (600 MHz for ^1^H and 150 MHz for ^13^C) spectrometer at 25 °C using TMS as internal standard. For analytical HPLC experiments, a LiChroCART RP18 column (250 × 4 mm, 5 μm) and a Merck Hitachi system consisting of an L-7100 pump, L-7200 autosampler, L-7455 diode array detector, and a D-7000 interface were used. Preparative reversed-phase HPLC was performed on a Varian R PrepStar SD-1 with Dynamax R solvent delivery system and an absorbance detector model UV-1 using a VDSpher 100 RP18 column (250 × 25 mm, 10 μm). For both, the mobile phase consisted of water (A) and ACN (B). The following gradient was used: 0--45 min, 70--100% B; 45--60 min, 100% B.

Plant Material {#sec3.2}
--------------

The dried roots of *O. paniculata* were purchased at a medicinal plant market in Kunming, China, in November 2003. They were identified macroscopically by Prof. Xiao-Jiang Hao, and the identity was confirmed based on its ITS and trnL-F regions by Prof. Guenther Heubl as described previously.^[@ref17]^ A voucher specimen is deposited at the herbarium of the Institute for Plant Sciences, University of Graz, Austria.

Extraction and Isolation {#sec3.3}
------------------------

The petroleum ether extract was prepared by Soxhlet extraction.^[@ref17]^ A 400 mg aliquot of this extract was dissolved in MeOH (40 mg/mL) and fractionated using preparative HPLC. Seven fractions were collected, from which fractions 2, 4, 6, and 7 gave **1** (1.1 mg), **2** (31.1 mg), **3** (48.6 mg), and **4**+**5** (46.3 mg), respectively.

### β-Hydroxyisovalerylshikonin (**1**): {#sec3.3.1}

red powder; CD (*c* 2.5 mM, CHCl~3~) \[θ\]~315~ −15 450, \[θ\]~365~ +15 910; ^1^H NMR (CDCl~3~, 400 MHz) data, see Table S1 [Supporting Information](#notes-1); ^13^C NMR (CDCl~3~, 100 MHz) data, see Table S2 [Supporting Information](#notes-1).

### Acetylshikonin (**2**): {#sec3.3.2}

red powder; CD (*c* 5.0 mM, CHCl~3~) \[θ\]~305~ −1470, \[θ\]~356~ +1650; ^1^H NMR (CDCl~3~, 600 MHz) data, see Table S1 [Supporting Information](#notes-1); ^13^C NMR (CDCl~3~, 150 MHz) data, see Table S2 [Supporting Information](#notes-1).

### Dimethylacrylshikonin (**3**): {#sec3.3.3}

red powder; CD (*c* 4.0 mM, CHCl~3~) \[θ\]~315~ −990, \[θ\]~359~ +540; ^1^H NMR (CDCl~3~, 400 MHz) data, see Table S1 [Supporting Information](#notes-1).

### α-Methylbutyrylshikonin (**4**) and Isovalerylshikonin (**5**): {#sec3.3.4}

red powder; ^1^H NMR (CDCl~3~, 600 MHz) data, see Table S1 [Supporting Information](#notes-1); ^13^C NMR (CDCl~3~, 150 MHz) data, see Table S2 [Supporting Information](#notes-1).

Sample Preparation {#sec3.4}
------------------

The compounds were freshly dissolved in DMSO, subsequently diluted with medium, and used immediately. Control cells represent vehicle-treated cells (0.5% DMSO). The final DMSO concentration did not affect the cells.

Cell Culture {#sec3.5}
------------

Human CCRF-CEM leukemia and MDA-MB-231 breast cancer cells lines were maintained in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, USA), supplemented with 2 mM [l]{.smallcaps}-glutamine (Sigma-Aldrich), 10% fetal bovine serum (FBS, PAA Laboratories, Pasching, Austria), 100 units/mL penicillin (PAA), and 100 μg/mL streptomycin (PAA) (1% penicillin/streptomycin). Human U251 glioblastoma and HCT 116 colon cancer cell lines were grown in high-glucose Dulbecco\'s modified Eagle medium (DMEM, Sigma-Aldrich) supplemented with 2 mM [l]{.smallcaps}-glutamine, 10% FBS, and 1% penicillin/streptomycin. Human SBcl2, WM35, WM9, and WM164 melanoma cell lines were grown in RPMI 1640 medium with 2 mM [l]{.smallcaps}-glutamine, 2% FBS, and 1% penicillin/streptomycin. Human MRC-5 lung fibroblasts were grown in minimum essential medium (MEM, Gibco, Invitrogen, Vienna, Austria) supplemented with 2 mM [l]{.smallcaps}-glutamine, 10% FBS, and 1% penicillin/streptomycin. All cells were kept in a humidified 5% CO~2~ atmosphere at 37 °C and passaged at 90% confluence. The cell cultures were periodically checked for the presence of mycoplasma by PCR.

XTT Viability Assay {#sec3.6}
-------------------

The XTT viability assay was performed as described previously^[@ref17]^ and in accordance with the manufacturer\'s protocol (Roche Diagnostics, Mannheim, Germany; cell proliferation kit II (XTT), cat. no 11 465 015 001). In brief, 10 000 cells/well in the case of CCRF-CEM and MRC-5 cells and 5000 cells/wells for the other cell lines were seeded into 96-well plates (100 μL, flat bottom) and treated with various concentrations of **1**--**3** or **4**+**5** for 72 h. Adherent cell lines were grown overnight before the test compounds were added. After 72 h, a freshly prepared XTT solution (5 mL of XTT plus 100 μL of electron coupling reagent) was added and analyzed after another 1.5 or 4 h (CCRF-CEM cells) using a Victor^2^ 1420 multilabel counter (PerkinElmer Life Sciences, Waltham, MA, USA). Vinblastine served as positive control (0.01 μM).

Cell-Cycle Analysis {#sec3.7}
-------------------

Cells were treated with the respective IC~50~ concentration for 12--72 h and harvested by trypsinization. Then, 5 × 10^5^ cells were fixed with 70% ice-cold EtOH for 10 min at 4 °C. After washing with PBS, the cell pellet was resuspended in propidium iodide (PI) staining buffer (50 μL/mL PI, RNase A, Beckman Coulter, Krefeld, Germany) and incubated at 37 °C for 15 min. Cell-cycle distribution was analyzed using a FACSCalibur flow cytometer (BD Biosciences, Heidelberg, Germany) using Modfit Software version 3.0 (Verity Software House, Topsham, ME, USA).

Caspase-Glo 3/7Assay {#sec3.8}
--------------------

For this assay, 10 000 cells/well (100 μL) were treated with the respective test-compound IC~50~ concentration for 6--72 h and analyzed for caspase activation using the Caspase-Glo 3/7 assay (Promega Corporation, Madison, WI, USA), according to the manufacturer\'s protocol. Luminescence was measured 30 min after adding the Caspase-Glo 3/7 reagent (Caspase-Glo substrate and buffer).

Statistical Analysis {#sec3.9}
--------------------

Statistical analysis was carried out using SigmaPlot 12.0 (Systat Software Inc., Chicago, IL, USA). IC~50~ values were determined using the four-parameter logistic curve, at least eight concentrations of the test compound, and two different cell passages each tested in three independent wells. Results are expressed as mean ± SEM.

^1^H and ^13^C NMR spectroscopic data of **1**--**5**, photographs of morphological changes (24 and 48 h) caused by **3** and **4**+**5**, as well as the effects of compounds **4**+**5** on the cell-cycle (12--72 h) distribution and activation of caspase 3/7 (6--72 h). This information is available free of charge via the Internet at <http://pubs.acs.org>.
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